跳至主要内容
临床试验/NCT05440721
NCT05440721撤回不适用

Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification

Click Therapeutics, Inc.1 个研究点 分布在 1 个国家开始时间: 2018年10月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
Primary Outcome Measure:

研究概览

简要总结

This study is evaluating the efficacy of Treatment A for short-term smoking cessation through a blinded randomized controlled trial (RCT) vs.Treatment B.

详细描述

The overarching study aim is to recruit a population of current smokers who are motivated to quit with the assistance of a mobile solution, enroll them into a study testing apps to help them quit, and randomize them into one of two arms. The core study period will consist of 8 weeks of usage of Treatment A or Treatment B. At the end of this period, users will receive notifications to link them to an online survey, which will record their responses in a secure database.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Age 18 to 65
  • •Smokes at least 5 cigarettes daily
  • •Is interested in quitting in the next 30 days
  • •Owns an iPhone with iOS 9 or higher or Android with OS 4.1 or higher
  • •Willing and able to receive SMS text messages
  • •Able to comprehend the English-language and the informed consent form
  • •Lives in the United States
  • •One half of the study sample will be recruited from the general population of smokers via social media advertisements
  • •One half of the study sample will be recruited via mail from a Magellan Behavioral Health value-based care network

排除标准

  • •Prior use of Clickotine or QuitGuide
  • •Current use of pharmacotherapy for smoking cessation or nicotine replacement therapy (NRT)

研究组 & 干预措施

Treatment A (device Clickotine®)

Active Comparator

User will open and use Treatment A (Clickotine® device) several times a day up to their quit date to complete a program of 21 Missions.

干预措施: Treatment A with device Clickotine® (Active intervention) (Device)

Treatment B (smoking education)

Sham Comparator

Treatment B app provides education and support to smokers seeking to quit. When a user has a craving or wants support or education, they can log into the app.

干预措施: Treatment B with smoking education (control) (Device)

结局指标

主要结局

Primary Outcome Measure:

时间窗: [Time Frame: 8 week core study]

The primary objective is to confirm the improved efficacy of CKT for short-term smoking cessation through a blinded randomized controlled trial (RCT) vs. QuitGuide. \*\*Acceptance criteria: Self-reported 30 day point prevalence quit rates will be significantly higher in the CKT arm than QuitGuide.

次要结局

  • Secondary Outcome Measure([Time Frame: 8 week core study])

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验